1. Nemec A, Murphy B, Kass PH, et al. Histological subtypes of oral non-tonsillar squamous cell carcinoma in dogs. J Comp Pathol 2012; 147: 111–120.
2. Gardner DG. Spontaneous squamous cell carcinomas of the oral region in domestic animals: a review and consideration of their relevance to human research. Oral Dis 1996; 2: 148–154.
3. Brodey RS. A clinical and pathologic study of 130 neoplasms of the mouth and pharynx in the dog. Am J Vet Res 1960; 21: 787–812.
4. Todoroff RJ, Brodey RS. Oral and pharyngeal neoplasia in the dog—a retrospective survey of 361 cases. J Am Vet Med Assoc 1979; 175: 567–571.
5. Liptak JM, Withrow SJ. Cancer of the gastrointestinal tract. In: Withrow SJ, Vail DM, eds. Withrow & MacEwen's small animal clinical oncology. 4th ed. St Louis: Saunders Elsevier, 2007; 567–571.
6. Pereira MC, Oliveira DT, Landman G, et al. Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc 2007; 73: 339–344.
7. Barnes L, Eveson JW, Reichart P, et al. World Health Organization classification of tumours—pathology and genetics of head and neck tumours. Lyon, France: IARC Press, 2005.
8. Lambert R, Sauvaget C, de Camargo Cancela M, et al. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol 2011; 23: 633–641.
9. Murphy S, Hayes A, Adams V, et al. Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma—a case series of five dogs. J Small Anim Pract 2006; 47: 216–220.
10. de Matos FR, Lima E, Queiroz LM, et al. Analysis of inflammatory infiltrate, perineural invasion, and risk score can indicate concurrent metastasis in squamous cell carcinoma of the tongue. J Oral Maxillofac Surg 2012; 70: 1703–1710.
11. Vieira FL, Vieira BJ, Guimaraes MA, et al. Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: correlation with the expression of Ki67 and histologic grading. BMC Oral Health 2008; 8: 25.
12. Chatzistamou I, Rodriguez J, Jouffroy T, et al. Prognostic significance of tumor shape and stromal chronic inflammatory infiltration in squamous cell carcinomas of the oral tongue. J Oral Pathol Med 2010; 39: 667–671.
13. Kosovsky JK, Matthiesen DT, Marretta SM, et al. Results of partial mandibulectomy for the treatment of oral tumors in 142 dogs. Vet Surg 1991; 20: 397–401.
14. White RAS. Mandibulectomy and maxillectomy in the dog—long-term survival in 100 cases. J Small Anim Pract 1991; 32: 69–74.
15. Wallace J, Matthiesen DT, Patnaik AK. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 1992; 21: 337–341.
16. Clarke BS, Mannion PA, White RA. Rib metastases from a nontonsillar squamous cell carcinoma in a dog. J Small Anim Pract 2011; 52: 163–167.
17. Herring ES, Smith MM, Robertson JL. Lymph node staging of oral and maxillofacial neoplasms in 31 dogs and cats. J Vet Dent 2002; 19: 122–126.
18. Owen LN. TNM classification of tumours in domestic animals. Geneva: World Health Organization, 1980.
19. Dunning D. Oral Cavity. In: Slatter DH, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: Saunders, 2003; 553–572.
20. Lantz GC. Maxillectomy and mandibulectomy techniques. In: Verstraete FJM, Lommer MJ, Bezuidenhout AJ, eds. Oral and maxillofacial surgery in dogs and cats. New York: Saunders/Elsevier, 2012; 451–481.
21. Fulton A, Arzi B, Murphy B, et al. The expression of calretinin and cytokeratins in canine acanthomatous ameloblastoma and oral squamous cell carcinoma [published online ahead of print Sep 17, 2012]. Vet Comp Oncol doi: 10.1111/j.1476-5829.2012.00356.x.
22. Strafuss AC, Cook JE, Smith JE. Squamous cell carcinoma in dogs. J Am Vet Med Assoc 1976; 168: 425–427.
23. Withrow SJ, Holmberg DL. Mandibulectomy in the treatment of oral-cancer. J Am Anim Hosp Assoc 1983; 19: 273–286.
24. Bradley RL, MacEwen EG, Loar AS. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. J Am Vet Med Assoc 1984; 184: 460–463.
25. Salisbury SK, Richardson DC, Lantz GC. Partial maxillectomy and premaxillectomy in the treatment of oral neoplasia in the dog and cat. Vet Surg 1986; 15: 16–26.
26. Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg 2008; 66: 1570–1579.
27. Agni NA, Prasad GSV, Borle RM, et al. Assessment of perineural infiltration and spread of oral squamous cell carcinoma: a clinicohistopathologic study. Indian J Cancer 2010; 47: 199–205.
28. Marcus B, Arenberg D, Lee J, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma—the impact of tumor-associated macrophages. Cancer 2004; 101: 2779–2787.
29. Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 2010; 46: 630–635.
30. Liao CT, Huang SF, Chen IH, et al. Tongue and buccal mucosa carcinoma: is there a difference in outcome? Ann Surg Oncol 2010; 17: 2984–2991.
31. Carpenter LG, Withrow SJ, Power BE. Squamous cell carcinoma of the tongue in 10 dogs. J Am Anim Hosp Assoc 1993; 29: 17–24.
32. Evans SM, Shofer F. Canine oral nontonsillar squamous-cell carcinoma—prognostic factors for recurrence and survival following orthovoltage radiation-therapy. Vet Radiol 1988; 29: 133–137.
33. Beck ER, Withrow SJ, McChesney AE, et al. Squamous cell carcinoma of the tongue in 10 dogs. J Am Anim Hosp Assoc 1986; 22: 525–532.
34. Regezi JA, Sciubbba JJ, Jordan RCK. Oral pathology: clinical pathologic correlations. 5th ed. Philadelphia: WB Saunders Co, 2008.
35. Coletta RD, Cotrim P, Almeida OP, et al. Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study. Oral Oncol 2002; 38: 723–729.
36. Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2010; 34: 676–688.
37. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29: 167–178.
38. Kan Y, Yamashita H, Le Pavoux A, et al. Histological changes after single high-dose irradiation for squamous cell carcinoma arising from a burn scar. Med Oncol 2010; 27: 86–90.
39. Larsen SR, Johansen J, Sorensen JA, et al. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 657–662.
Advertisement
Objective—To identify risk factors associated with survival in dogs with nontonsillar oral squamous cell carcinoma (OSCC) that were and were not treated with curative-intent surgery.
Design—Retrospective case series.
Animals—31 dogs with OSCC.
Procedures—Medical records for dogs with OSCC that were not treated, or were treated with curative-intent surgery only between January 1990 and December 2010 were reviewed. For each dog, data regarding signalment, clinical stage, treatment, tumor recurrence, and survival time were obtained from the medical record, and archived biopsy specimens were evaluated to identify the histologic subtype of the tumor and extent of tumor-associated inflammation (TAI), perineural invasion (PNI), and lymphovascular invasion (LVI).
Results—Risk of death for the 21 dogs with OSCC that were surgically treated was decreased 91.4% (hazard ratio, 0.086; 95% confidence interval, 0.002 to 0.150), compared with that for the 10 dogs with OSCC that were not treated. The 1-year survival rate was 93.5% and 0% for dogs that were and were not surgically treated, respectively. Risk of death increased significantly with increasing TAI and increasing risk score (combination of TAI, PNI, and LVI). Tumor location, clinical stage, and histologic subtype were not associated with survival time.
Conclusions and Clinical Relevance—Results indicated that the prognosis for dogs with OSCC was excellent following surgical excision of the tumor. Risk of death increased with increasing TAI, and combining TAI, PNI, and LVI into a single risk score may be a useful prognostic indicator for dogs with OSCC.
The authors declare that they have no conflict of interest and received no outside funding for completion of the study reported here.